So-Lo-Mo Intervention Applied to the Smoking Cessation Process

• Status: Completed
• Trial end date: 2018-10-24
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized open-label parallel-group trial. 240 subjects will be recruited during 8 months and a 12 months follow-up will be carried out for each one of them. The sample will split in two groups: control group (n=120) who will receive usual psycho-pharmacological therapy and the intervention group (n=120) who will receive usual therapy plus So-Lo-Mo app.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
• Collaborators: Andaluz Health Service; European Commission
• Treatments: Bupropion; Varenicline

Criteria

Inclusion Criteria:

• Smoking population attending to the Smoking Cessation Unit of "Virgen del Rocío" University Hospital.

• Subjects >18 years old who want to give up smoking.

• Android-based smart phone availability.

• Ability to interact with the smart phone.

• To sign an Informed Consent Form.

Exclusion Criteria:

• Subjects had some previous adverse effects related to the pharmacological treatment included in the study